
Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment
Partnership to accelerate enrollment and diversity in neurovascular clinical research. SAN FRANCISCO - November 16, 2022 - Viz.ai, the leader in...
Nov 16, 2022
Explore our latest resources
Partnership to accelerate enrollment and diversity in neurovascular clinical research. SAN FRANCISCO - November 16, 2022 - Viz.ai, the leader in...
Nov 16, 2022
Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients. SAN FRANCISCO – November 15,...
Nov 15, 2022
AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients...
Oct 31, 2022
Part of the Viz PE Solution, new algorithm flags key patient risk indicator of pulmonary embolism severity. SAN FRANCISCO – September...
Sep 01, 2022
The Viz.ai team has been busy this summer attending several vascular events, meeting with clinical leaders advancing the vascular surgery...
Aug 24, 2022
Viz.ai uses artificial intelligence to streamline aortic care coordination across geographies. Viz AORTIC offers a multidisciplinary team approach and concept...
May 24, 2022
Diagnosis and care coordination of patients suffering from pulmonary embolism (PE) can be challenging, with the average arrival-to-treatment times lasting...
Nov 16, 2021
Viz.ai is expanding into cardiovascular disease to address the vulnerabilities in coordinating care in pulmonary embolism and aortic disease The...
Sep 01, 2021
Viz.ai is adding to their software suite tools to triage cases of aortic dissection (AD) & pulmonary embolism (PE). The...
Aug 03, 2021